It is a pleasure to announce the 1st ASPIC International Congress to be held in Lisbon, 25-26 November 2014.

The Portuguese Association for Cancer Research – ASPIC – was officially created in February 2013 and, after a kick-off meeting on “Public Benefit of Cancer Research”, held in 2013 (http://www.aspic.pt/pt-pt/conference2013#fade), is now preparing its 1st Congress.

The program has an outstanding group of invited speakers from Portugal and abroad and ample time for discussion in Plenary Symposia as well as Oral and Poster sessions. A joint Symposium ASEICA-ASPIC addresses new research approaches and will establish a link with cancer researchers from Spain, with lectures by Manuel Serrano, Paula Soares and Goreti Sales. Other symposia will cover early cancer detection (lecture by Rebecca Fitzgerald), cancer genes and what we have learned from them (lectures by Moshe Oren, Manuel Teixeira and Branca Cavaco), and mechanisms and implications of tumour heterogeneity (lectures by Samuel Aparicio and Luís Costa).

The scope of the congress is necessarily limited – it is a one and a half day event – but the poster session will be open to presentations in all cancer research areas (we know we eventually learn more listening about subjects that are outside our “small world”). Everybody is most welcome to listen, to discuss and to participate. Even for those outside the “biobox”, such as chemists and physicists, there will be space for discussions and even for “burning news” at the final session of the congress.

The topics of the congress and the high quality of the speakers are attractive to a wide range of professionals and researchers. We expect to bring together most cancer researchers from Portugal and also from Spain and other countries. The scientific program and the congress venue – Fundação Calouste Gulbenkian – will synergize to make this congress a great moment for the cancer research community.

I am confident this is the first of many ASPIC Congresses to come!

Kind regards,


  1. Meet researchers who share a common interest in cancer research
  2. Establish new interdisciplinary research collaborations
  3. Present your research and increase the public awareness for cancer research in Portugal
  4. Promote the national cancer research community centered on ASPIC
  5. Attract R&D investment and promote fund raising activities
  6. Share the benefits of being a member of ASPIC and EACR ​​​


The 1st ASPIC International Congress was accredited by the European Accreditation Council on CME (EACCME) with 9 hours of European external CME credits.